If you are a med safety nurse and planning to attend the American Society of Health-System Pharmacists meeting in Boston for the medication safety program, please consider participating in the "Great safety Debate on Monday afternoon, June 10, 2019.
ASHP has been conducting The Great Safety Debate at their annual Summer Meetings for the past three years, focused on various medication safety topics. This year we hope to have two unique teams each consisting of a medication safety resident/fellow, a nurse, and a pharmacist. The three debate topics this year are:
• Should sublingually-administered sufentanil tablets be available on hospital formulary?
• Is “family-controlled analgesia” (as opposed to patient-controlled analgesia or PCA by proxy) an appropriate modality for treating severe pain in children?
• Is there a significant role for intravenous promethazine in treating nausea and vomiting?
If you are interested, please send a note and a brif background/cv to Mike Dejos, Pharm.D., the medication safety officer at Nemours/Alfred I. DuPont Hospital (email@example.com). Mike needs to know of your interest by February 11th. A selection committee will review all applicants for the debate and make a final determination of participants. We hope that you will consider applying to participate in this debate.